“You don’t have to make all the mistakes yourself” - this September’s raft of ASTP-Proton training courses are lining up to make a real impact on the professional development and network community of the participants.
In order to assist its researchers in providing this information, KU Leuven Research & Development (technology transfer office of KU Leuven) has developed a mandatory Patent Inventor Form.
Samples of human biological material are used for many purposes and are of increasing importance as the funders of research, whether public, charitable or commercial, prioritise areas which rely upon access to human biological samples.
Though the scale and substance of collaborations varies, a basic understanding of intellectual property rights (IPR) within the Chinese context may help to maximize the success of joint cooperation.
More and more innovation is driven by research collaborations between different entities. Within the context of globalized economy, these research and innovation collaborations are becoming increasingly internationalised.
The efficiency of drug delivery to the lungs depends on various parameters, some of which are influenced by the inhalation system being utilised.
With the 1,25-dihydroxy vitamin D blood tests manufactured by IDS, doctors and patients have an additional tool to diagnose and manage CKD.
Gene therapy used to be a far-off idea in the medical world, but with the trailblazing approval of the world’s first gene therapy product, Glybera, a normal life may no longer be a dream for patients with genetic illnesses.
The University of Leuven has created a three-minute self-screening method for discovering hearing problems, which is now being used in schools and offices.
UK’s top supplier of disinfectant wipes partnered with Cardiff University to produce clinical proof that a sporicidal wipe can kill the resilient bacterium, Clostridium Difficile. Their award winning partnership has yielded more positive outcomes than they hoped for.
This diagnostic tool provides images of both the front and back surfaces of the cornea for a more accurate picture to guide medical procedures.
After decades of research, scientists have discovered a drug that engages the immune system to fight B-precursor acute lymphoblastic leukemia, a rare and aggressive type of cancer.
Join our newsletter and get the latest news